About LAMINAR
LAMINAR is a Healthcare company based in Santa Rosa (United States) founded in 2019, and was acquired by Johnson & Johnson in November 2023. Provider of catheter based left atrial appendage closure device. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Cardival Medical, Saranas and Aziyo Biologics; 3 of its 3 listed competitors have raised funding.
Company details
LAMINAR was founded in 2019 and is located in Santa Rosa, United States. Medical devices focused on cardiology are developed and supplied by the company. A catheter-based closure device is offered for use by surgeons in treating thromboembolic strokes associated with atrial fibrillation. The technology targets structural issues in the left atrial appendage to support patient care in this sector. Operations emphasize device provision for clinical applications.
- Headquarters Santa Rosa, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website laminarlaa.com
- Acquired by Johnson & Johnson (Nov 2023)
- Investors
- Acquired byJohnson & Johnson
(Nov 2023)
Investors in LAMINAR
LAMINAR has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Johnson & Johnson.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | jnj.com | New Brunswick, United States |
Investor details for LAMINAR
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of LAMINAR
2 dated milestones of LAMINAR across 4 years, from founding to its latest funding, stage changes and deals.
- Founded LAMINAR is founded.
- Exit Acquired by Johnson & Johnson.
Competitors of LAMINAR
LAMINAR has 3 listed competitors in our database, 3 of them funded. They include Cardival Medical, Saranas and Aziyo Biologics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cardivamedical.com | 2002 | Santa Clara, United States | $169.45M | 158 | A device for vascular access management is developed. | |
| saranas.com | 2011 | Houston, United States | $29.46M | A device is developed for detecting internal bleeding during catheterization. | ||
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. |
Detailed competitors of LAMINAR
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as LAMINAR (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Laminar
Complete news archive for LAMINAR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LAMINAR
LAMINAR was founded in 2019.
LAMINAR is headquartered in Santa Rosa, United States.
LAMINAR was founded in 2019 and is located in Santa Rosa, United States. Medical devices focused on cardiology are developed and supplied by the company. A catheter-based closure device is offered for use by surgeons in treating thromboembolic strokes associated with atrial fibrillation. The technology targets structural issues in the left atrial appendage to support patient care in this sector. Operations emphasize device provision for clinical applications.
LAMINAR's top competitors include Cardival Medical, Aziyo Biologics and Saranas.
LAMINAR has 1 investor. Key investors include Johnson & Johnson.
Yes. LAMINAR was acquired by Johnson & Johnson in November 2023.